ストックスクリーナーアプリを入手
25.75
2.10%
0.53
アフターアワーズ：
25.75
前日終値:
$25.22
開ける：
$25.6
24時間の取引高:
768.20K
Relative Volume:
0.68
時価総額：
$1.48B
収益：
$2.28B
当期純損益:
$-1.13B
株価収益率:
-1.2966
EPS:
-19.86
ネットキャッシュフロー:
$35.92M
1週間 パフォーマンス:
+14.44%
1か月 パフォーマンス:
+17.21%
6か月 パフォーマンス:
-13.24%
1年 パフォーマンス:
-28.35%
1日の値動き範囲:
$24.83
$25.85
1週間の範囲:
$22.93
$26.50
52週間の値動き範囲:
$19.14
$35.40
Enovis Corp Stock (ENOV) Company Profile
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
25.75 | 1.48B | 2.28B | -1.13B | 35.92M | -19.86 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-17 | 再開されました | William Blair | Outperform |
| 2026-01-06 | 開始されました | BTIG Research | Buy |
| 2024-10-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-06-13 | 開始されました | JP Morgan | Neutral |
| 2024-02-13 | 開始されました | Stephens | Overweight |
| 2024-01-22 | 開始されました | UBS | Buy |
| 2024-01-03 | 開始されました | William Blair | Outperform |
| 2023-12-15 | 繰り返されました | Needham | Buy |
| 2023-10-20 | 開始されました | ROTH MKM | Buy |
| 2023-06-26 | 開始されました | Needham | Buy |
| 2023-05-12 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-10-11 | 開始されました | Goldman | Buy |
| 2022-09-12 | 開始されました | Canaccord Genuity | Buy |
| 2022-09-12 | 開始されました | Evercore ISI | Outperform |
| 2022-06-28 | 開始されました | Argus | Hold |
| 2022-06-27 | 再開されました | Loop Capital | Buy |
| 2022-06-16 | 開始されました | Wells Fargo | Equal Weight |
すべてを表示
Enovis Corp (ENOV) 最新ニュース
CD&R Engages Former Enovis CEO as Operating Advisor - AOL.com
BMO Capital Initiates Enovis at Outperform With $29 Price Target - marketscreener.com
Does Enovis (ENOV) Leaving Russell Defensive Indexes Signal A Deeper Shift In Its Risk Profile? - simplywall.st
Enovis (ENOV) Coverage Started with Outperform Rating and $29 Ta - GuruFocus
American Century affiliates report 10.6% holdings in Enovis (ENOV) - Stock Titan
Enovis (ENOV) Following CMS Reversal, Why The Valuation Story Is Back In Focus - simplywall.st
Why Enovis (ENOV) Stock Is Trading Up Today - Yahoo Finance
Enovis shares jump after Medicare reverses reimbursement cuts By Investing.com - Investing.com Nigeria
Enovis shares jump after Medicare reverses reimbursement cuts - Investing.com
BTIG Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $39 - Moomoo
Enovis Q1 2026 slides: earnings beat forecast, margins expand - Investing.com
Tarkio Fund's Enovis Corp(ENOV) Holding History - GuruFocus
Enovis (ENOV) director Christine Ortiz receives 846-share stock award - Stock Titan
Form 4 Enovis Corp For: 1 July By Investing.com - Investing.com India
Enovis Corp (ENOV) Stock Down 6.0% -- Now Undervalued? GF Score: 60/100 - GuruFocus
How Investors Are Reacting To Enovis (ENOV) Russell 2000 Defensive Index Removal And Rebalancing - simplywall.st
Enovis stock hits 52-week low at 20.45 USD - Investing.com
Enovis stock hits 52-week low at 20.45 USD By Investing.com - Investing.com Australia
Enovis Corporation(NYSE: ENOV) dropped from Russell 2000 Defensive Index - marketscreener.com
Enovis (ENOV) Could Be 46% Undervalued As Net Profit Jumps 84% - simplywall.st
Enterprise value to revenue forward of Enovis Corporation – NYSE:ENOV - TradingView
Enterprise value to revenue forward of Enovis Corporation – LSE:0I1B - TradingView
Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh - TradingView
Enterprise value to EBITDA forward of Enovis Corporation – NYSE:ENOV - TradingView
Price to sales forward of Enovis Corporation – NYSE:ENOV - TradingView
Enovis Corp (ENOV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
What's Driving the Recent Buzz Around Enovis (ENOV) Stock - Kavout | AI
Enovis Corp (ENOV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Enovis Corporation Actuals & Estimates (NYSE:ENOV) - TradingView
C520 Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Enovis Corporation – NYSE:ENOV - TradingView
Enovis Corporation Actuals & Estimates (FWB:C520) - TradingView
ENOV Forecast — Price Target — Prediction for 2027 - TradingView
ENOVEnovis Corp Short Interest - Finviz
Enovis Corp (ENOV) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tranche Update on Enovis Corporation's Equity Buyback Plan announced on February 16, 2018. - marketscreener.com
ENOV Technical Analysis & Stock Price Forecast - Intellectia AI
Enovis (ENOV) Slides Over 3% as Shares Approach Key Support at $20.23Imbalance Zone - Město Břeclav
Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Raises Target Price to $36 - 富途牛牛
Enovis Corp (ENOV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enovis Corp (ENOV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enovis Corp (ENOV) Institutional Confidence - TradingKey
Enovis (ENOV) Q4 2025 earnings summary - Quartr
Enovis Corporation (ENOV) Surges 5.37%: Momentum Building Above Key SupportWyckoff Distribution - dars.gov.et
Enovis Corp (ENOV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Enovis Corp (ENOV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Enovis Corp (ENOV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enovis (ENOV) Stock Could Be 49.8% Undervalued After Spinamic Brace Launch - simplywall.st
Insider Buying: Oliver Engert Acquires Additional Shares of Enovis Corp (ENOV) - GuruFocus
Enovis Corp (ENOV) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
大文字化:
|
ボリューム (24 時間):